Reference · Updated 30 September 2026
Transparency disclosure deadlines by country
When and where pharmaceutical companies disclose transfers of value to healthcare professionals and organisations in the UK and Europe. Each row links to the official source; national rules can change, so check the source before each reporting cycle.
| Market | Framework | Where | When | Source |
|---|---|---|---|---|
| Europe (EFPIA baseline) | EFPIA Code of Practice 2026, Chapter 5 | Company website or a central platform | Annually, within six months after the end of the calendar year; common publication window 20–30 June. Public for at least 3 years; records kept for at least 5. | EFPIA Code of Practice 2026 |
| United Kingdom | ABPI Code, Clauses 28–31 | Disclosure UK | 2026 data: submission by 14:00 BST on 31 March 2027; gateway links by 23 June 2027; publication on 30 June 2027. | ABPI: Disclosure UK |
| Germany Country guide | FSA-Transparenzkodex | Company website or a central external platform | No later than six months after the reporting period; the report should be published between 20 and 30 June of the following year, in German. | FSA-Transparenzkodex (English service translation) |
| Ireland Country guide | IPHA Code of Practice | IPHA Central Report (transferofvalue.ie) | Within six months after the reporting period; patient organisation information updated by 30 June each year. | IPHA Code of Practice |
| Spain Country guide | Farmaindustria Code | Company websites | Each June, for transfers of value made in the previous year. | Farmaindustria: transparency initiative |
| Italy Country guide | Farmindustria Codice Deontologico | Company website | By 30 June of the following year. The statutory Sanità trasparente register (Legge 62/2022) should be checked for operational status. | Farmindustria Codice Deontologico |
| Netherlands Country guide | Transparantieregister Zorg | Transparantieregister Zorg | Companies report before 1 June of the following year; data is published in mid-July. Threshold: at least €500 per calendar year. | Transparantieregister Zorg: for companies |
| Portugal Country guide | Estatuto do Medicamento, Article 159 | INFARMED transparency platform | Within 30 days of granting a benefit; recipients have 30 days to confirm or dispute the entry. | Estatuto do Medicamento, Art. 159 (INFARMED consolidated text) |
| Sweden Country guide | Lif ethical rules (LER) | Published annually, in Swedish, with a methodology note | Annual reporting; searchable, downloadable reports from the 2027 publication of 2026 transfers. | Lif: ethical rules |
| France Country guide | Loi Bertrand (Loi n° 2011-2012) | Transparence Santé public database | Statutory declarations on Transparence Santé; check the current declaration deadlines on the official site. | Transparence Santé |
Sources checked 30 September 2026. Informational summary, not legal advice. See also: EFPIA disclosure requirements · Disclosure UK guide · UK & EU Pharma Compliance Guide 2026